Skip to content

Biodesix, Inc. BDSX Change in Deferred Revenue

Change in Deferred Revenue at other companies

Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$4M+220%
Personalis, Inc. logo
Personalis, Inc.PSNL
$2.61M+329%
Guardant Health logo
Guardant HealthGH
-$3.23M-233%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-$19.3M-55.9%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$627K-208%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$5.2M+528%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s change in deferred revenue?
Biodesix, Inc. (BDSX) reported change in deferred revenue of -$766K in Q1 2026.
How has Biodesix, Inc.'s change in deferred revenue changed year-over-year?
Biodesix, Inc.'s change in deferred revenue decreased by 1022.9% year-over-year, from $83K to -$766K.
What is the long-term trend for Biodesix, Inc.'s change in deferred revenue?
Over 2 years (2021 to 2023), Biodesix, Inc.'s change in deferred revenue has grown at a -34.7% compound annual growth rate (CAGR), from -$1.77M to -$755K.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.